• 1. School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan 250000, P.R.China;
  • 2. The Second Department of Surgery, Shandong Tumor Hospital, Jinan 250000, P.R.China;
ZUO Wenshu, Email: cjcptzws@126.com
Export PDF Favorites Scan Get Citation

Objective  To understand breast cancer 1 (BRCA1) gene and relationship between BRCA1 gene and breast cancer, and analyze its effect on clinical comprehensive therapy of breast cancer. Method  The domestic and international studies relevant BRCA1 and breast cancer in recent years were reviewed and summarized. Results  BRCA1, a tumor suppressor gene, its mutations caused structural changes and functional abnormalities, which were closely related to breast cancer. And the expression situation and mutation of BRCA1 were associated with the therapeutic effect. Conclusions  Mutation of BRCA1 is closely related to occurrence and development of breast cancer in female. Comprehensive therapy ideas should be found in clinical therapy according to expression or mutation of BRCA1. Further research on BTCA1 is beneficial to explore gold standard for treatment of breast cancer.

Citation: ZHA Guosong, ZUO Wenshu. Research progress of BRCA1 and breast cancer. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2017, 24(7): 900-904. doi: 10.7507/1007-9424.201610040 Copy

  • Previous Article

    Venous thromboembolism prophylaxis after hepatectomy
  • Next Article

    Research progress of liver metastasis in breast cancer